New anti-AB vaccine could help halt Alzheimer's progression, preclinical study finds

ScienceDaily
Oct 20, 2020, 1:56 pm359 pts
A preclinical study by neuroscientists indicates that an antigen-presenting dendritic vaccine with a specific antibody response to oligomeric A-beta may be safer and offer clinical benefit in treating Alzheimer's disease. The vaccine uses immune cells known as dendritic cells loaded with a modified A beta…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Thursday’s Headlines Lobby Congress 129

Climate change made heat and dryness that fueled Iberian wildfires 40 times more likely, study finds 122

Climate Deniers to Converge on Reform Conference 117

A tiny embryo fold changed the course of evolution 116

Meat is macho: Why masculinity concepts get in the way of green initiatives to cut meat and dairy consumption 113

Countries' carbon budget math is broken—study finds bias in calculations 111

PFAS water treatment has double benefits, cutting toxic 'forever chemicals' and carcinogens 103

What the EPA's plan to deregulate greenhouse gas emissions means for Washington state 102

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.